• Resources
  • Blog
  • Journalists
  • Webcasts
  • Data Privacy
  • Français
  • my CNW 
    • Login
    • Register
  • Client Login 
    • Online Member Centre
    • Next Gen Communications Cloud
    • Cision Communications Cloud®
  • Sign Up
  • Send a Release
Cision Canada
  • News
  • Products
    • Overview
    • Cision Communications Cloud®
    • Monitoring
    • Distribution
    • Multimedia
    • Measurement & Analytics
    • IR
  • Contact
    • Become a Client
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • General Enquiries
    • Media
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
Advanced Search
    Advanced Search
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Canadian Federal Government
      • Canadian Municipal Government
      • Canadian Provincial Government
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

  • Overview
  • Cision Communications Cloud®
  • Monitoring
  • Distribution
  • Multimedia
  • Measurement & Analytics
  • IR
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media
  • Worldwide Offices
  • Cision Canada
  • Send a Release
  • FR
    • Phone

    • 877-269-7890 from 8 AM - 10 PM ET

    • ALL CONTACT INFO
    • Contact Cision

      877-269-7890
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR
  • Overview
  • Cision Communications Cloud®
  • Monitoring
  • Distribution
  • Multimedia
  • Measurement & Analytics
  • IR
  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR

New tools, support and information on insulin use now available to Canadians living with Type 2 diabetes aiming to maintain healthy blood glucose levels


News provided by

Sanofi Canada

Apr 12, 2018, 08:00 ET

Share this article

Share this article


* Panel of Canadian experts recommend new ways to overcome barriers Canadians face when trying to achieving their target glucose (blood sugar) levels.1

LAVAL, QC, April 12, 2018 /CNW Telbec/ - Faced with the knowledge that an estimated 1.5 million Canadians living with diabetes2 are not able to achieve their glycemic targets3, a panel of Canadian Experts was brought together by sanofi-aventis Canada Inc. (Sanofi Canada) to address the common barriers people face in reaching their target glucose levels. The recommendations can be found in the newly published article in the Diabetes Therapy Journal4 entitled "INSULIN MATTERS: A practical approach to Basal Insulin Management in Type 2 Diabetes regarding Basal Insulin Management". The panel of experts includes general practitioners (GPs), nurses, nurse practitioners, endocrinologists, dietitians, pharmacists and a psychologist.

Continue Reading

Related Documents

Infographic: Break down the barriers to insulin initiation and take charge of your Type 2 Diabetes today! (CNW Group/Sanofi Canada)
View PDF
Infographic: Break down the barriers to insulin initiation and take charge of your Type 2 Diabetes today! (CNW Group/Sanofi Canada)

The newly published article outlines insights from the panel's multidisciplinary expertise in diabetes management with advice and solutions to address barriers many Canadians face when trying to achieving their target glucose levels. These new tools and resources found in the recommendations showcase the panel's in-depth understanding of the Type 2 diabetes (T2D) management and demystify insulin and its use. From fear of needles and potential undesirable effects, the recommendations highlight how insulin initiation can help patients lead a healthy life along with the help of their Health Care Team.

Why insulin matters

Canadians with T2D may need to take insulin to achieve their target glucose levels and to reduce their risks of complications such as heart disease, kidney disease, loss of vision and amputation of the lower limbs.

Since insulin introduction (initiation) and dose increase (intensification) are important factors in the management of diabetes5,6,7,8, the panel's goal was to help break down and address barriers that people living with T2D may face regarding insulin.

"We identified some barriers from patients that might contribute to delaying the initiation and intensification of insulin in people living with T2D, which could explain why some Canadians are not achieving their target glucose levels. Healthcare professionals will now have more tools and resources to address these barriers in order to better help their patients manage their condition," says Dr. Michael Vallis, Clinical Psychologist, Diabetes Management Centre, Capital Health and Dalhousie University, Halifax, Nova Scotia, Canada.

Health Care Team key to success

Health care teams are a vital resource for Canadians to learn about the tools available for managing their diabetes. Canadians can learn about their target glucose levels, healthy eating and exercise plans and the best treatment options including their insulin initiation plan. 

"It is important to encourage and to educate people living with T2D on self-management with the help of their Health Care Team who can demonstrate how the pens and needles work, to self-monitor blood glucose and to prevent and treat hypoglycemia. Reinforcing a healthy lifestyle is also imperative," mentions Sarah Blunden, Certified Diabetes Educator and Professional Dietitian, LMC Diabetes and Endocrinology, Montreal, Quebec, Canada.

Insulin initiation

Insulin is a natural replacement hormone therapy9 that can be used when the pancreas is unable to produce enough on its own, due to the progressive nature of T2D.10,11,12,13,14

A new generation of long-acting basal insulins such as insulin glargine 300 U/mL (Gla-300), marketed under the name Toujeo®, approved by Health Canada in 2015, and which has been studied in a large clinical program15, makes it possible to lower the amount of glucose in the blood. Since this basal insulin is long-acting, it only needs to be taken once a day, helping Canadians maintain a healthy and active lifestyle, not limited by their medication.

"We are confident that these new resources will help Canadians to achieve their target glucose levels and in turn, improve their quality of life", commented Dr. Upender Mehan, FCFP, Waterloo Wellington LHIN, Kitchener, Ontario, Canada.

"We at Sanofi Canada are convinced that the energy and efforts invested by health care professionals and our teams can contribute to helping patients receive the best care they need according to the available treatments stemming from the latest advances in diabetes management research," concluded  Dr. Hisham A.S. Mahmoud, Medical Director at Sanofi Canada.

To access the "INSULIN MATTERS: A practical approach to Basal Insulin Management in Type 2 Diabetes regarding Basal Insulin Management" article, please click here.

About Sanofi Diabetes and Cardiovascular

Diabetes and cardiovascular disease affect millions of people worldwide, with many managing the complex challenges of both. Building on its portfolio evolution, heritage and expertise, Sanofi has implemented a focused business unit dedicated to delivering innovative, value-based medicines and integrated solutions in these therapeutic areas. It is committed to a collaborative approach that involves strategic alliances with professional and patient associations, research institutions and leaders in healthcare and other industries, with the goal of advancing scientific knowledge, driving the convergence of science and technology, helping to improve outcomes and inspiring an evolution in care.

About Sanofi www.sanofi.ca

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Consumer Healthcare. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Together, Sanofi entities in Canada employ close to 1,900 people. In 2016, Sanofi companies invested $130 million in research and development in Canada, creating jobs, economic activity and opportunity throughout the country.

Follow us on Twitter @SanofiCanada and on YouTube.

____________________________________

1Leiter, L.A., et al., Type 2 diabetes mellitus management in Canada: is it improving? Can J Diabetes, 2013. 37(2): p. 82-9.

2https://www.diabetes.ca/about-diabetes.

3Leiter, L.A., et al., Type 2 diabetes mellitus management in Canada: is it improving? Can J Diabetes, 2013. 37(2): p. 82-9.

4https://link.springer.com/article/10.1007/s13300-018-0375-7.

5Khunti, K., et al., Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin. Diabetes Obes Metab, 2016. 18(4): p. 401-9.

6Paul, S.K., et al., Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes. Cardiovascular Diabetology, 2015. 14(1): p. 100.

7Khunti, K., Clinical inertia in the management of type 2 diabetes mellitus: a focused literature review. The British Journal of Diabetes, 2015. 15(2): p. 65-69.

8Khunti, K., et al., Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care, 2013. 36(11): p. 3411-7. doi: 10.2337/dc13-0331. Epub 2013 Jul 22.

9Polonsky, W.H. and R.A. Jackson, What's So Tough About Taking Insulin? Addressing the Problem of Psychological Insulin Resistance in Type 2 Diabetes. Clinical Diabetes, 2004. 22(3): p. 147-150.

10DeFronzo, R.A., R. Eldor, and M. Abdul-Ghani, Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes. Diabetes Care, 2013. 36 Suppl 2: p. S127-38.

11Pratley, R.E., The early treatment of type 2 diabetes. Am J Med, 2013. 126(9 Suppl 1): p. S2-9.

12Barag, S.H., Insulin therapy for management of type 2 diabetes mellitus: strategies for initiation and long-term patient adherence. J Am Osteopath Assoc, 2011. 111(7 Suppl 5): p. S13-9.

13Ross, S.A., Breaking down patient and physician barriers to optimize glycemic control in type 2 diabetes. Am J Med, 2013. 126(9 Suppl 1): p. 012.

14Palumbo, P.J., The case for insulin treatment early in type 2 diabetes. Cleve Clin J Med, 2004. 71(5): p. 385-6.

15Ritzel, R., Roussel, R., Bolli, G. B., Vinet, L., Brulle-Wohlhueter, C., Glezer, S., & Yki-Järvinen, H., Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes. Diabetes, Obesity and Metabolism, 2015. 17(9), 859-867.

SOURCE Sanofi Canada

For further information: Sanofi Canada, Catherine R. Cunningham, Tel.: 514-713-1634, [email protected]; Massy Forget Langlois Public Relations, Bridget Ann Peterson, Tel.: 514-842-2455, ext. 26, [email protected]

Related Links

http://www.sanofi.ca

Modal title

Organization Profile

Sanofi Canada

    Also from this source

  • Sanofi Canada named one of Forbes Canada's Best Employers for 2022...

  • Sanofi Canada supports Canada's Walk of Fame in its induction of...

Contact Cision

  • 877-269-7890
    from 8 AM - 10 PM ET

  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media
  • Worldwide Offices

Products

  • Cision Communications Cloud®
  • Media Monitoring
  • Content Distribution
  • Multimedia Distribution
  • Measurement & Analytics
  • Investor Relations

About

  • About Cision Canada
  • About Cision
  • Media Partners
  • Careers
  • Accessibility Statement

My Services

  • All News Releases
  • Online Member Centre
  • Next Gen Communications Cloud
  • Cision Communications Cloud®
  • my CNW

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Centre
  • Next Gen Communications Cloud
  • Cision Communications Cloud
  • my CNW
877-269-7890
from 8 AM - 10 PM ET
  • Terms of Use
  • Information Security Policy
  • Site Map
  • Cookie Settings
  • Accessibility Statement
Copyright © 2022 CNW Group Ltd. All Rights Reserved. A Cision company.